Upgrade to SI Premium - Free Trial

Xenetic Biosciences (XBIO)

2.17 -2.10 (49.18%)

Chart
Today 6M 1Y 5Y

Upcoming Events

- Earnings (11/6/26)

Latest Headlines

Xenetic Biosciences to acquire Santersus AG in all-stock deal September 16, 2026 7:01 AM - StreetInsider Form 8-K Xenetic Biosciences, For: Sep 14 September 16, 2026 7:01 AM - SEC Filing Xenetic Biosciences and Santersus AG Announce Definitive Share Exchange Agreement to Create Global Leader in NET-Targeting Therapeutics September 16, 2026 7:00 AM - StreetInsider Form 8-K Xenetic Biosciences, For: Aug 07 August 7, 2026 8:35 AM - SEC Filing Xenetic Biosciences Reports Second Quarter 2026 Financial Results and Highlights Strengthened Scientific Foundation Supporting Continued Advancement of Proprietary DNase Platform August 7, 2026 8:35 AM - StreetInsider Form 10-Q Xenetic Biosciences, For: Jun 30 August 6, 2026 4:36 PM - SEC Filing Full Article List